Clinical Trial Detail

NCT ID NCT03553004
Title Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Anup Kasi
Indications

pancreatic adenocarcinoma

Therapies

Niraparib

Age Groups: adult senior

No variant requirements are available.